z-logo
open-access-imgOpen Access
The influence of ACYP2 polymorphisms on gastrointestinal cancer susceptibility in the Chinese Han population
Author(s) -
Duan Xianglong,
Hong Jiajing,
Wang Fuchun,
Wei Kun,
Wang Pengyuan,
Hou Feng,
Zhang Min,
Liu Dengfeng,
Yuan Dongya,
Liu Sida
Publication year - 2019
Publication title -
molecular genetics and genomic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.765
H-Index - 29
ISSN - 2324-9269
DOI - 10.1002/mgg3.700
Subject(s) - medicine , colorectal cancer , gastrointestinal cancer , genotype , cancer , allele , gastroenterology , logistic regression , oncology , intestinal cancer , gene , genetics , biology
Background Gastrointestinal cancer (GI cancer) is a type of cancer that has a high death rate. It has been reported that ACYP2 gene was associated with the development of gastric cancer and colorectal cancer, but it is not clear that the relationship between ACYP2 gene and GI cancer in Chinese Han population. This study aimed to investigate the association between polymorphisms of ACYP2 and GI cancer in the Chinese Han population. Methods We used Agena MassARRAY to determine the genotypes of 1,160 GI cancer patients and 495 healthy controls. The correlation between ACYP2 variants and GI cancer risk was examined by logistic regression analysis. Results We identified that rs6713088 (OR = 1.17, 95% CI: 1.00–1.36, p  = 0.047), rs843711 (OR = 1.17, 95 CI: 1.01–1.36, p  = 0.035), and rs11896604 (OR = 1.20, 95% CI: 1.00–1.45, p  = 0.048) were correlated with an increased risk of GI cancer under allele model. Rs11125529 under the recessive model (OR = 2.05, 95% CI: 1.00–4.23, p  = 0.038), rs843711 in recessive model (OR = 1.37, 95% CI: 1.04–1.82, p  = 0.026), and rs11896604 under log‐additive model (OR = 1.23, 95% CI: 1.01–1.51, p  = 0.042) were associated with an increased risk of GI cancer. Conclusion Our study suggested that polymorphisms of ACYP2 gene might be associated with susceptibility to GI cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here